Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Treatment sequencing for patients with localized duodenal and ampullary adenocarcinoma.
Authors
Abhishek Janardan
Medical College of Wisconsin, Milwaukee, WI;
Abhishek Janardan , Ben George , Gulrayz Ahmed , Sherin Daniel , Bicky Thapa , Maahum Mehdi , Lisa Rein , Aniko Szabo , Beth Erickson , William A. Hall , Kathleen K. Christians , Susan Tsai , Douglas B. Evans , Mandana Kamgar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 783)
DOI
10.1200/JCO.2023.41.4_suppl.783
Abstract #
783
Poster Bd #
N5
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical relevance of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma who underwent surgery following neoadjuvant modified FOLFIRINOX.
First Author: So Heun Lee
Poster
2020 Gastrointestinal Cancers Symposium
Treatment modalities and oncological outcomes in Mexican patients with localized gastric cancer.
First Author: Haydee Cristina Verduzco-Aguirre
Poster
2019 Gastrointestinal Cancers Symposium
Survival outcomes between surgery with adjuvant therapy compared to neoadjuvant therapy with surgery in stage I pancreatic adenocarcinoma: Results from a large national cancer database.
First Author: Samit Kumar Datta
Poster
2024 ASCO Annual Meeting
Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer.
First Author: Darren Lee